BioLineRx Ltd.
BLRX
$3.28
-$0.06-1.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.21M | 28.16M | 26.37M | 19.56M | 29.17M |
| Total Receivables | 699.00K | 281.00K | 1.92M | 3.86M | 3.96M |
| Inventory | 2.18M | 2.85M | 3.32M | 3.15M | 3.54M |
| Prepaid Expenses | 432.00K | 572.00K | 312.00K | 443.00K | 1.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 91.00K | -- |
| Total Current Assets | 28.52M | 31.86M | 31.92M | 27.10M | 37.85M |
|
|
|||||
| Total Current Assets | 28.52M | 31.86M | 31.92M | 27.10M | 37.85M |
| Net Property, Plant & Equipment | 892.00K | 997.00K | 1.16M | 1.35M | 1.65M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 10.39M | 10.41M | 10.43M | 10.45M | 13.25M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 39.80M | 43.27M | 43.51M | 38.91M | 52.74M |
|
|
|||||
| Total Accounts Payable | 3.54M | 3.47M | 4.69M | 5.58M | 4.63M |
| Total Accrued Expenses | 2.13M | 2.77M | 1.75M | 3.13M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.78M | 4.89M | 5.12M | 5.00M | 10.34M |
| Total Finance Division Other Current Liabilities | 3.23M | 4.36M | 2.46M | 1.69M | 9.99M |
| Total Other Current Liabilities | 3.23M | 4.36M | 2.46M | 1.69M | 9.99M |
| Total Current Liabilities | 13.67M | 15.48M | 14.03M | 15.41M | 24.96M |
|
|
|||||
| Total Current Liabilities | 13.67M | 15.48M | 14.03M | 15.41M | 24.96M |
| Long-Term Debt | 5.60M | 6.72M | 7.63M | 8.96M | 17.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.00M | 998.00K | 985.00K | 1.08M | 1.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.27M | 23.20M | 22.65M | 25.45M | 44.24M |
|
|
|||||
| Common Stock & APIC | 400.69M | 399.29M | 396.20M | 391.79M | 387.44M |
| Retained Earnings | -399.62M | -398.64M | -394.70M | -399.83M | -396.64M |
| Treasury Stock & Other | 18.47M | 19.42M | 19.37M | 21.50M | 17.71M |
| Total Common Equity | 19.53M | 20.07M | 20.86M | 13.46M | 8.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.53M | 20.07M | 20.86M | 13.46M | 8.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.53M | 20.07M | 20.86M | 13.46M | 8.51M |
|
|
|||||